Antagonism by suramin of the growth-inhibitory effect of hydroxytamoxifen and doxorubicin in human MCF-7 breast cancer cells.
Berthois
Y
Y
Laboratoire de Cancérologie Expérimentale, Faculté de Médecine secteur Nord, Marseille, France.
Dong
X F
XF
Martin
P M
PM
Cvitkovic
E
E
D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D004317:Doxorubicin / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D004347:Drug Interactions; D004351:Drug Resistance; D006801:Humans; D013498:Suramin / Q000494:pharmacology*; D013629:Tamoxifen / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D013629:Tamoxifen; D013498:Suramin; D004317:Doxorubicin